Cisapride + Placebo
ApprovedTerminated 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Gastroparesis
Conditions
Gastroparesis, Diabetes Mellitus
Trial Timeline
Jul 1, 2003 → Oct 1, 2003
NCT ID
NCT01286090About Cisapride + Placebo
Cisapride + Placebo is a approved stage product being developed by Johnson & Johnson for Gastroparesis. The current trial status is terminated. This product is registered under clinical trial identifier NCT01286090. Target conditions include Gastroparesis, Diabetes Mellitus.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01286090 | Approved | Terminated |
| NCT01281540 | Approved | Terminated |
Competing Products
19 competing products in Gastroparesis
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| tadalafil + tadalafil + placebo | Eli Lilly | Phase 2 | 52 |
| Granisetron | Kyowa Kirin | Phase 2 | 52 |
| tadalafil | Eli Lilly | Approved | 85 |
| Mosapride + domperidone | Sumitomo Pharma | Approved | 85 |
| Cisapride + Placebo | Johnson & Johnson | Approved | 85 |
| Naloxegol 25 MG Oral Tablet [Movantik] + Placebo Oral Tablet | AstraZeneca | Phase 2 | 52 |
| Sitagliptin + Placebo | Merck | Phase 1 | 33 |
| Tegaserod | Novartis | Approved | 85 |
| Reglan ODT | UCB | Pre-clinical | 20 |
| Hemin + Albumin | Recordati | Phase 2 | 49 |
| CNSA-001 + Placebo | PTC Therapeutics | Phase 2 | 49 |
| Immediate-release omeprazole + Delayed-release omeprazole | Bausch Health | Approved | 80 |
| Velusetrag + Placebo | Theravance Biopharma | Phase 2 | 47 |
| velusetrag dose 1 + velusetrag dose 2 + velusetrag dose 3 + placebo | Theravance Biopharma | Phase 2 | 47 |
| IW-9179 + Matching Placebo | Ironwood Pharmaceuticals | Phase 2 | 44 |
| VLY-686 (Tradipitant) | Vanda Pharmaceuticals | Phase 2 | 44 |
| Tradipitant | Vanda Pharmaceuticals | Phase 3 | 69 |
| Tradipitant | Vanda Pharmaceuticals | Pre-clinical | 15 |
| Tradipitant + Placebo + Open Label Tradipitant | Vanda Pharmaceuticals | Phase 3 | 69 |